Loading...
PD-L1 in melanoma: facts and myths
The use of monoclonal antibodies that block immunologic checkpoints that would otherwise mediate the adaptive immune resistance have paved the way in cancer treatment. There is evidence that blocking the PD-1/PD-L1 axis is a strategy of overriding importance in the treatment of patients with metasta...
Na minha lista:
| Udgivet i: | Melanoma Manag |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Future Medicine Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096437/ https://ncbi.nlm.nih.gov/pubmed/30190888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2016-0013 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|